吕万良团队在干细胞仿生脂质体激活免疫重建治疗白血病研究方面取得进展

中国药学(英文版) ›› 2022, Vol. 31 ›› Issue (7): 556-557.

吕万良团队在干细胞仿生脂质体激活免疫重建治疗白血病研究方面取得进展

北京大学药学院天然药物及仿生药物国家重点实验室

北京大学药学院天然药物及仿生药物国家重点实验室

收稿日期:2022-07-23 修回日期:2022-07-25 接受日期:2022-07-25 出版日期:2022-07-31 发布日期:2022-07-31

The group of Professor Wanliang Lu has made progress in the research of stem cell biomimetic liposomes carrying levamisole for macrophage immunity reconstruction in leukemia therapy

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2022-07-23 Revised:2022-07-25 Accepted:2022-07-25 Online:2022-07-31 Published:2022-07-31

摘要/Abstract

Supporting:

北京大学药学院天然药物及仿生药物国家重点实验室. 吕万良团队在干细胞仿生脂质体激活免疫重建治疗白血病研究方面取得进展[J]. 中国药学(英文版), 2022, 31(7): 556-557.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The group of Professor Wanliang Lu has made progress in the research of stem cell biomimetic liposomes carrying levamisole for macrophage immunity reconstruction in leukemia therapy[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(7): 556-557.